Miserez AR - Search Results

1

Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.

Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR. Berneis K, et al. Among authors: miserez ar. Metabolism. 2005 Feb;54(2):227-34. doi: 10.1016/j.metabol.2004.08.017. Metabolism. 2005. PMID: 15690318

2

TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B. Meier C, et al. Among authors: miserez ar. J Clin Endocrinol Metab. 2001 Oct;86(10):4860-6. doi: 10.1210/jcem.86.10.7973. J Clin Endocrinol Metab. 2001. PMID: 11600554 Clinical Trial.

3

Apolipoprotein E3Basel: new insights into a highly conserved protein region.

Miserez AR, Scharnagl H, Muller PY, Mirsaidi R, Stähelin HB, Monsch A, März W, Hoffmann MM. Miserez AR, et al. Eur J Clin Invest. 2003 Aug;33(8):677-85. doi: 10.1046/j.1365-2362.2003.01180.x. Eur J Clin Invest. 2003. PMID: 12864777

4

VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.

Zulewski H, Ninnis R, Miserez AR, Baumstark MW, Keller U. Zulewski H, et al. Among authors: miserez ar. J Lipid Res. 1998 Feb;39(2):380-7. J Lipid Res. 1998. PMID: 9507998 Free article.

5

Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.

Miserez AR, Keller U. Miserez AR, et al. Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1719-29. doi: 10.1161/01.atv.15.10.1719. Arterioscler Thromb Vasc Biol. 1995. PMID: 7583549

6

High prevalence of familial defective apolipoprotein B-100 in Switzerland.

Miserez AR, Laager R, Chiodetti N, Keller U. Miserez AR, et al. J Lipid Res. 1994 Apr;35(4):574-83. J Lipid Res. 1994. PMID: 8006512 Free article.

7

Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls.

Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ. Zulewski H, et al. Among authors: miserez ar. J Clin Endocrinol Metab. 1997 Mar;82(3):771-6. doi: 10.1210/jcem.82.3.3810. J Clin Endocrinol Metab. 1997. PMID: 9062480

8

Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolaemia.

Muller PY, Miserez AR. Muller PY, et al. Among authors: miserez ar. Atheroscler Suppl. 2004 Dec;5(5):1-5. doi: 10.1016/j.atherosclerosissup.2004.09.002. Atheroscler Suppl. 2004. PMID: 15556092

9

Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects.

Miserez AR, Rossi FA, Keller U. Miserez AR, et al. Eur J Clin Pharmacol. 1994;46(2):107-14. doi: 10.1007/BF00199871. Eur J Clin Pharmacol. 1994. PMID: 8039527

10

Familial defective apolipoprotein B-100: A review.

Andersen LH, Miserez AR, Ahmad Z, Andersen RL. Andersen LH, et al. Among authors: miserez ar. J Clin Lipidol. 2016 Nov-Dec;10(6):1297-1302. doi: 10.1016/j.jacl.2016.09.009. Epub 2016 Sep 22. J Clin Lipidol. 2016. PMID: 27919345 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters